January 06, 2009

Eurand Inc. et al v. Impax Laboratories Inc.

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. September 19, 2012

    Judge Keeps Sales Ban In Cephalon Generic Amrix Patent Row

    A Delaware federal judge on Tuesday extended an injunction barring Impax Laboratories Inc. from selling a generic version of Cephalon Inc.'s muscle relaxant Amrix, after an appeals court ruling set a Sept. 15 expiration date on a standing injunction.


Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS